Beta v1.0
Partnering with Principal Investigators to Accelerate Trial Allocation
Connecting clinical sites, academic medical centers, and private investigative clinics directly with biopharma sponsors. We eliminate corporate bureaucracy, streamline CTA/budget contracting, and offer clinician-to-clinician liaison backing led by Mohammad Alajarmeh, M.D.
Why Investigators Partner with Eunoia
Removing legacy CRO roadblocks so you can focus on patient care and data purity.
Rapid CTA & Budget Execution
No waiting months for committee layers. Direct executive leadership ensures swift Clinical Trial Agreement (CTA) and site budget approvals.
Clinician-to-Clinician Support
Principal Investigators communicate directly with Mohammad Alajarmeh, M.D., ensuring protocol clarifications and endpoint reviews are handled expertly.
Transparent Compensation
Transparent pass-through billing model without hidden administrative markups, predatory clawbacks, or delayed milestone payments.
Dual Regional Corridors
Active site coordination anchored across South Florida’s patient population and expanding into the Boston-Worcester Biotech Corridor.
How Sites Join Our Clinical Network
Profile Submission
Submit your site capabilities, PI credentials, therapeutic specialties, and active patient cohort data.
Capabilities Audit
Eunoia Health audits facility equipment, GCP compliance status, and historical trial execution telemetry.
Trial Matching
Pre-approved sites are immediately routed into feasibility pipelines for incoming biopharma sponsor RFIs.
Fast-Track Activation
Accelerated CTA signing, rapid site activation, and continuous M.D. operational liaison oversight.
Register Site / Principal Investigator Profile
Submissions route directly to 03_Site_PI_Onboarding Vault